
01
1. Intended use
2. Test principle
The Digital Fertility Testing System is composed of the Digital Fertility Tracker
and Test Midstreams. The Digital Fertility Testing System is intended to be
used for the qualitative or semi-quantitative detection hormone in human
urine.
For LH: for the semi-qualitative detection of luteinizing hormone (LH) in urine,
as an aid in predicting the time of ovulation, and peak fertility.
For FSH: for the qualitative detection of follicle stimulation hormone (FSH) in
urine to evaluate the decrease of fertility.
For hCG: for the qualitative detection of human chorionic gonadotropin
(hCG) in urine, as an early detection of pregnancy.
The Digital Fertility Testing System is intended for self-testing outside the
body (in vitro diagnostic use).
The Digital Fertility Testing System is a lateral flow sandwich immunoassay
employing monoclonal antibodies that are specifically directed against the
coating and labeling antibody. During the test procedures, the user collects
a sample in a clean, dry container and dips the sample pad into the
collected sample until the LED light begins to fast flash (which usually takes
30 seconds). After the urine sample is applied to the device, the substance to
be tested in the sample will react with the monoclonal antibody conjugate of
the substance to be tested obtained by mouse immunization. Conjugated
complexes migrate along the membrane to the test and control regions. The
digital component integrated with the chromatographic strip displays the
results of immunochemical reaction on the LED lamp of the equipment. After
the equipment self-calibration procedure is completed, the LED will start
Thank you for purchasing
For the safe use of this product, please read this User Manual first, and keep
it properly after reading so that you may access and consult at any time. The
warranty card is also included in the package. Please do not lose it. EN